Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene expression data of organoids derived from human pancreatic tumor and normal pancrea samples.

ABSTRACT: Gene expression data of organoids derived from human pancreatic tumor and normal pancrea samples.

PROVIDER: PRJNA420762 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Gene expression data of organoids derived from human pancreatic tumor and normal pancrea samples.

Project description:We analyzed gene expression of 39 patient-derived pancreatic tumor, 6 normal-like, 2 normal and 10 engineered organoids.

2018-02-08 | GSE107610 | GEO

Expression data from Mayo Clinic Pancreatic Tumor and Normal samples

Project description:We used microarrays to identify the expression differences of FKBP5 gene between the pancreatic tumor and normal samples.On average normal samples had more FKBP5 expression compared to tumor samples

2009-06-10 | GSE16515 | GEO

Expression data of cultured organoids derived from human colorectal tumors and normal samples.

Project description:We analyzed gene expression of 58 line patinet-derived colorectal tumors and normal organoids.

2016-05-26 | GSE74843 | GEO

Affymetrix Arrays Interrogated with Tumor/Normal Pancreatic Samples

2011-07-01 | GSE22780 | GEO

Affymetrix Arrays Interrogated with Tumor/Normal Pancreatic Samples

Project description:To identify genes in the chromosome 3p12 pathway to tumorigenesis in pancreatic cancer, we screened two expression platforms and then as a third platform interrogated pancreatic cancer tumor/normal samples for differential expression. Data from the third expression platform experiments are shown herein. Frozen tumor and adjacent normal tissue were obtained from untreated, retrospective pancreatic adenocarcinoma samples available from the M. D. Anderson Cancer Center tumor bank and our collaborator (MLF). Total RNA from matched tumor/adjacent normal samples (8 paired samples) was utilized to interrogate the GeneChip U133 plus 2.0 array and resultant bioinformatic analysis performed to identify differentially expressed sequences across all three platforms.

2011-07-01 | E-GEOD-22780 | biostudies-arrayexpress

Gene expression data of organoids derived from human gastric tumor and normal stomach samples.

Project description:Recent sequencing analyses have shed light on heterogeneous patterns of genomic aberrations in human gastric cancers (GCs). To explore how individual genetic events translate into cancer phenotypes, we established a biological library consisting of genetically engineered gastric organoids carrying various GC mutations and 37 patient-derived organoid lines, including rare genomically stable GCs. Phenotype analyses of GC organoids revealed divergent genetic and epigenetic routes to gain Wnt and R-spondin niche independency. An unbiased phenotype-based genetic screening identified a significant association between CDH1/TP53 compound mutations and the R-spondin independency that was functionally validated by CRISPR-based knockout. Xenografting of GC organoids further established the feasibility of Wnt-targeting therapy for Wnt-dependent GCs. Our results collectively demonstrate that multifaceted genetic abnormalities render human GCs independent of the stem cell niche and highlight the validity of the genotype-phenotype screening strategy in gaining deeper understanding of human cancers.

2018-08-14 | GSE112369 | GEO

Expression data from patient-derived pancreatic cancer organoids with gene engineering

Project description:Lineage plasticity often emerges in human cancer along with clinical progression and exposure to chemotherapy. Although lineage transition is evident in an aggressive subtype of human pancreatic cancer characterized by the loss of the ductal identity and manifestation of squamous cell-like features, the drivers of these processes have remained elusive. We here harmonized organoid technology, molecular profiling and gene engineering and found that the H3K27me3-mediated erasure of the ductal identity and lineage specifiers, and hijacking of the TP63-driven squamous-cell program provide environmental fitness. Induction and fixation of the squamous-cell identity was dependent on Wnt-deficient environment, whereas KDM6A loss or a hypoxic niche licensed tumor cells for squamous reprogramming. EZH2 inhibition counterbalanced the epigenetic bias and curbed the growth of pancreatic cancer organoids with squamous features. Our results demonstrate how adversarial microenvironment dictates the molecular and histological evolution of human pancreatic cancer, and provide insights into the principles and significance of lineage conversion in human cancer. We used microarray gene expression analysis to study the effect of delta-Np63 overexpression and TP63 knockout in patient-derived pancreatic cancer organoids or genetically engineered organoids.

2024-06-30 | GSE263236 | GEO

Expression Analysis of Normal and Neoplastic Mouse Pancreatic Ductal Organoids

Project description:This study used Illumina strand-specific, paired-end RNA-sequencing to examine gene expression differences between normal and neoplastic mouse pancreatic ductal cells grown as three-dimensional, organoid cultures. The study analyzed 19 independently derived organoid lines. These 19 lines included 7 biological replicate "mN," or mouse normal, organoid lines, derived from the pancreatic ductal cells of wild-type C57Bl/6J or C57Bl/6N mice. In addition, the study analyzed 6 biological replicate "mP," or mouse PanIN, organoid lines, derived from PanIN-containing mouse pancreata from the KrasLSL-G12D; Pdx1-Cre mouse model. (The presence of PanIN in the pancreata from which these organoid lines were derived was confirmed by examining histological sections from the same pancreata). The final 6 lines examined in this study were biological replicate "mT," or mouse tumor, organoid lines, derived from mouse pancreata containing pancreatic ductal adenocarcinoma (PDAC) from the KrasLSL-G12D; Trp53LSL-R162H; Pdx1-Cre mouse model. We genes differentially expressed in the PanIN- or tumor-derived mouse organoid lines, relative to the mouse normal organoids, that may reflect expression changes required for pancreatic tumorigenesis.

2014-12-30 | GSE63348 | GEO

Metformin-treated hESC-derived pancreatic organoids

Project description:Metformin-treated hESC-derived pancreatic organoids

| PRJNA549928 | ENA

Gene expression data of organoids derived from human gastric tumor and normal stomach samples.

Project description:Gene expression data of organoids derived from human gastric tumor and normal stomach samples.

| PRJNA445832 | ENA